C

Citius Oncology Inc
D

CTOR

1.73000
USD
0.03
(1.76%)
مغلق
حجم التداول
0
الربح لكل سهم
-0
العائد الربحي
-
P/E
-4
حجم السوق
144,478,255
المقالات

العنوان: Citius Oncology Inc

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.